drugset / Trial / NCT01021267

Clinical Study to Assess the Influence of a Saw Palmetto Preparation in Patients With Benign Prostatic Hyperplasia (BPH) and Sexual Dysfunctions

NCT01021267 ↗

Phase 4 Unknown 50 enrolled A. Vogel AG University of London · collab
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Assessment in an open trial if a standardized saw palmetto preparation has a positive influence on sexual dysfunctions in patients with BPH and sexual dysfunctions.

Timeline

Start
2009-11
Primary completion
2010-09
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Saw palmetto berry extract Unknown 320 mg —

Indications

No indication recorded.